Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Non Operating Income: 2011-2025

Historic Non Operating Income for Aytu Biopharma (AYTU) over the last 14 years, with Jun 2025 value amounting to -$512,000.

  • Aytu Biopharma's Non Operating Income fell 62.92% to $201,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$853,000, marking a year-over-year decrease of 203.02%. This contributed to the annual value of -$512,000 for FY2025, which is 158.85% down from last year.
  • Latest data reveals that Aytu Biopharma reported Non Operating Income of -$512,000 as of FY2025, which was down 158.85% from $870,000 recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Non Operating Income ranged from a high of $1.0 million in FY2022 and a low of -$2.0 million during FY2021.
  • In the last 3 years, Aytu Biopharma's Non Operating Income had a median value of $184,000 in 2023 and averaged $180,667.
  • In the last 5 years, Aytu Biopharma's Non Operating Income surged by 372.83% in 2024 and then slumped by 158.85% in 2025.
  • Aytu Biopharma's Non Operating Income (Yearly) stood at -$2.0 million in 2021, then spiked by 149.61% to $1.0 million in 2022, then slumped by 81.91% to $184,000 in 2023, then skyrocketed by 372.83% to $870,000 in 2024, then slumped by 158.85% to -$512,000 in 2025.